儿童癌症男性幸存者中的乳腺癌及继发性乳腺癌——特征与风险
该研究在7019名儿童实体瘤5年幸存者(治疗于2001年前法国,平均随访20年)中比较男女乳腺癌发生情况。3893名男性幸存者中4例发生乳腺癌,3126名女性幸存者中99例发生乳腺癌;4名男性均有放疗史,雌激素受体均阳性,3例孕激素受体阳性。作者认为男性乳腺癌是儿童癌症幸存者中罕见的第二恶性肿瘤,放疗是已知风险因素,但仅基于放疗史的常规筛查不被推荐。
要点
- 3893名男性幸存者中4例发生乳腺癌,3126名女性幸存者中99例发生乳腺癌。
- 4名男性乳腺癌患者均有放疗史,雌激素受体均阳性,3例孕激素受体阳性。
- 作者认为仅基于放疗史的常规筛查不被推荐,但出现可疑症状时需予以关注。
核心结论
- 男性乳腺癌是儿童癌症幸存者中罕见的第二恶性肿瘤。
- 放疗是已被确认的风险因素,但关于可能的基因突变还需要更多数据。
- 作者认为不推荐仅基于放疗史的常规筛查,但出现可疑症状时必须予以关注。
研究设计与样本
- 对2001年前在法国接受治疗的7019名儿童实体瘤(年龄≤20岁)5年幸存者进行队列分析,平均随访20年,比较男性和女性发生的乳腺癌。
主要发现
- 3893名男性幸存者中4例发生乳腺癌,3126名女性幸存者中99例发生乳腺癌。
- 4名男性乳腺癌患者均有放疗史。
- 4名男性乳腺癌患者雌激素受体均阳性,其中3例孕激素受体阳性。
临床怎么用
- 作者认为不推荐仅基于放疗史的常规筛查,但出现可疑症状时必须予以关注。
- 作者指出需要更多关于可能的基因突变的数据。
局限性
- 作者指出关于可能的基因突变还需要更多数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Male breast cancer (MBC) is uncommon, accounting for less than 1% of all breast cancers. Secondary breast cancers among childhood cancer survivors have been well described in the literature, but less is known about MBC. METHODS AND MATERIALS: We carried out an analysis in a cohort of 7019 five-year survivors of a solid childhood (aged ≤20 years) cancer treated in France before 2001 and followed for an average of 20 years and compared breast cancers occurring in both men and women. RESULTS: Among the 7019 survivors, 4 out of 3893 male survivors developed breast cancer, compared with 99 out of 3126 female survivors. All of the men had a history of radiation therapy. The 4 men with MBC had estrogen receptors and 3 had progesterone receptors. CONCLUSIONS: MBC is a rare second malignancy among childhood cancer survivors. Receipt of radiation therapy is a recognized risk factor, but more data about eventual genetic mutations are necessary. Regular screening based only on a history of radiation therapy is not recommended; however, attention must be given in the case of suspicious symptoms.
引用
- Demoor-Goldschmidt C, Allodji RS, Jackson A, et al. Breast Cancer, Secondary Breast Cancers in Childhood Cancer Male Survivors-Characteristics and Risks. Int J Radiat Oncol Biol Phys. 2018. PMID: 30096470. doi:10.1016/j.ijrobp.2018.07.2017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。